They are similar in reducing BP control, however, in literature, barnidipine has been reported to have a neutral tolerability profile with regard to insulin sensitivity21, indicating it might be particularly suitable for patients with metabolic syndrome, dyslipidemia, and impaired fasting glucose. This evidence concerns the gene INS and metabolic syndrome.